Dr. Masey M. Ross
Claim this profileVirginia Commonwealth University/Massey Cancer Center
Area of expertise
Breast Cancer
Masey M. Ross has run 10 trials for Breast Cancer. Some of their research focus areas include:
Breast Cancer
Masey M. Ross has run 9 trials for Breast cancer. Some of their research focus areas include:
Affiliated Hospitals
Virginia Commonwealth University/Massey Cancer Center
VCU Massey Cancer Center At Stony Point
Clinical Trials Masey M. Ross is currently running
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint High 2 Risk (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint High 2 Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting
2 awards
Phase 3
40 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting
2 awards
Phase 3
19 criteria
More about Masey M. Ross
Clinical Trial Related
2 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Masey M. Ross has experience with
- Paclitaxel
- Fulvestrant
- Quality-of-Life Assessment
- Durvalumab
- Chemotherapy
- Pembrolizumab
Breakdown of trials Masey M. Ross has run
Breast Cancer
Breast cancer
Lobular Carcinoma in Situ
Atypical Breast Hyperplasia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Masey M. Ross specialize in?
Masey M. Ross focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved HER2 negative patients, or patients who are HER2 positive.
Is Masey M. Ross currently recruiting for clinical trials?
Yes, Masey M. Ross is currently recruiting for 4 clinical trials in Richmond Virginia. If you're interested in participating, you should apply.
Are there any treatments that Masey M. Ross has studied deeply?
Yes, Masey M. Ross has studied treatments such as Paclitaxel, Fulvestrant, Quality-of-Life Assessment.
What is the best way to schedule an appointment with Masey M. Ross?
Apply for one of the trials that Masey M. Ross is conducting.
What is the office address of Masey M. Ross?
The office of Masey M. Ross is located at: Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia 23298 United States. This is the address for their practice at the Virginia Commonwealth University/Massey Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.